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Background. Because subintimal angioplasty (SA) is a technique that can achieve recanalization of long arterial occlu-
sions, it is considered an alternative to lower limb bypass operations. The aim of this prospective study was to identify
the risk factors that affect patency of SA in patients suffering from critical limb ischemia (CLI).
Methods and results. 51 consecutive infrainguinal SA were done in 46 patients suffered from CLI. The patients were
followed-up with regular duplex scans up to 12 months post-intervention. Sex, atherosclerosis risk factors, and some tech-
nical details of the procedure (number of patent run-off vessels after the procedure, length and re-entry point of angioplasty)
were examined as potential risk factors of patency, using survival analysis statistical techniques.
The overall patency rate at 12 months post-intervention was 50%. According to Cox-regression analysis, the factors
that affect patency were the number of run-off vessels and the length of occlusion. Patients with two or three run-off vessels
had a hazard of occlusion of 0.30 (P¼ .027) compared to those who had one run-off vessel. The 12-months patency in pa-
tients with more than one run-off vessels was 81% vs. 25% in patients with one run-off vessel. Regarding the length of
angioplasty, the hazard of reocclusion was 1.02 for every centimeter of occlusion (P¼ .049).
Conclusions. The number of patent run-off crural vessels after the angioplasty and the length of occlusion are significant
risk factors for reocclusion of infrainguinal SA in patients with CLI. Trying to recanalize more than one run-off vessels
could raise the SA patency.
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Lower limb subintimal angioplasty (SA) is now a well
known technique1 which can achieve recanalization of
long occluded arterial segments. It has been proposed
as an alternative to lower limb bypass procedures, es-
pecially in patients with critical lower limb ischemia.2
Much of the criticism about this technique is based on
its patency rate compared to bypass procedures.3 It
is often stated that the approximate 50%4,5 primary
patency rate at 12 months post-intervention is quite
low compared to the almost 80 to 90%6,7 for bypass
procedures. However, despite the relatively high reoc-
clusion rate, subintimal angioplasty allows an excep-
tionally good limb salvage rate in patients with limb
threatening ischaemia.5,8
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well defined. The aim of this prospective study was
to identify the factors that affect the patency of infrain-
guinal SA in patients with critical lower limb ischemia.
Materials and Methods
Aprospective studywasdesigned to assess the patency
of infrainguinal subintimal angioplasty in lower limbs
suffering from critical limb ischemia (CLI) and to iden-
tify the factors that affect it. The study involved hu-
mans, thus an ethics committee approvalwas obtained.
On 46 patients (24 males) suffering from critical
lower limb ischemia, 51 consecutive primary infrain-
guinal subintimal angioplasties were performed.
This cohort of patients included the total number of
patients treated for lower limb ischemia in our Vas-
cular Unit for a six months period. It is the policy in
this Unit to treat all patients suffering by critical
limb ischemia with a percutaneous angioplasty first.
The technique of this type of angioplasty has beenrved.
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luminal dissection is performed along the occluded
segment of the artery which is then followed by bal-
loon dilatation and the creation of a new lumen.
This technique achieves recanalization of long arterial
occlusions which cannot be treated by other types of
angioplasty as with transluminal angioplasty. Translu-
minal angioplasties, graft angioplasties and redo an-
gioplasties were excluded from this study.
All patients suffered from critical lower limb ische-
mia as defined in TransAtlantic InterSociety Consen-
sus Classification (Recommendations 73, 74).10 From
clinical point of view, 14 out of the 51 patients (27%)
suffered by rest pain, 32 (63%) by lower limb ulcers,
and 5 (10%) of them had a digital necrosis. The mor-
phology of occlusions in all patients were of type C
(5 cases, 10%) and type D (46 cases, 90%) according
to the TASC morphological stratification of femoropo-
pliteal and infrapopliteal lesions (Recommendations
34, 93).11 Thus, subintimal angioplasty was the only
treatment available to these patients with the excep-
tion of a femoro-popliteal or a femoro-distal bypass
operation.
All sites in the lower arterial tree were amenable to
angioplasty, as shown in Table 1. A flush occlusion of
superficial femoral artery (SFA) was not a contraindi-
cation of subintimal angioplasty, as a subintimal plane
on the SFA was always possible to be found even
without a profound stump of SFA. Also, long occlu-
sions of SFA, popliteal and even crural arteries (poste-
rior and anterior tibial and peroneal) were usually
attempted to be angioplastied. All patients received
antiplatelet treatment (Aspirin 75 mg) after the proce-
dure was completed. Patients were followed-up using
lower-limb arterial duplex scans at 1, 3, 6, 9 and 12
months after the procedure.
The variables examined as possible factors affect-
ing subintimal angioplasty patency rate were:
1. Sex
2. The risk factors of atherosclerosis (i.e. history of
arterial hypertension, history of ischemic heart
Table 1. Anatomical sites of occlusion






Crural (ie AT, PT, peroneal) 6 12
Femoropopliteal 27 53
Distal 24 47disease, history of diabetes mellitus and past his-
tory of smoking).
3. The number of patent crural vessels after the pro-
cedure (run-off vessels), in continuation with the
femoropopliteal segment.
4. The length of occluded arterial segment
recanalized.
5. The end-level of angioplasty. According to this
description, the procedures were considered as
femoropopliteal angioplasties, if the end-point was
the popliteal artery and as distal angioplasties, if
the end-point was one of the crural arteries (i.e.
anterior and posterior tibial or peroneal artery).
Statistical Methods
The primary patency rate on an intention-to-treat
basis of angioplastied vessels was calculated by the
survival analysis techniques (Life-table analysis and
Kaplan-Meier curve). All examined factors were uni-
variately related to the patency rate, and those that
showed even a slight effect on patency (ie p< 0.30)
were included in a model of multivariable analysis
in order to identify those that were significantly inde-
pendent factors of patency.12 The multivariable analy-
sis used was the proportional hazards model or Cox
regression analysis.13 The factors that were found to
affect patency significantly, according to the multivar-
iable analysis, were univariately related to the patency
so as to calculate the patency rates in the group of
patients that carry this factor and in the group of
patients that do not carry this factor. The statistical
differences between the survival curves of the various
groups examined were calculated using the Log-rank
test. Mann-Whitney U test was used to check age dif-
ference between males and females. All reported
p-values were two-tailed and considered significant
if less than 0.05. All analyses were performed using
Statsdirect Statistical Software (version 2.3.1).
Results
Twenty seven male (53%) and 24 female (47%)
patients were included in the trial. The age of the
patients varied from 43 to 95 years (median 80,
interquartile range 71 to 87). Female patients were
slightly older than male patients (median 81 vs. 77, in-
terquartile ranges 78 to 95 vs. 66 to 87), but this was
not statistically significant ( p¼ 0.12, Mann-Whitney
U test). The prevalence of risk factors of atherosclero-
sis in our patient’ cohort varied from 39 to 54% as
shown in Table 2.Eur J Vasc Endovasc Surg Vol 32, December 2006
670 A. M. Lazaris et al.Twenty-seven (53%) femoropopliteal and 24 (47%)
distal angioplasties were performed (Table 1). One
patent run-off vessel was present after the procedure
in 25 (49%) cases and more than one (two or three)
vessels in 26 (51%) (Table 3). The length of the
occluded arterial segment varied from 5 to 80 cm
(median 30, interquartile range 20 to 45). Technical
success, i.e. recanalization of the occluded arterial seg-
ment with antegrade flow into the pedal arch at the
end of the procedure, was achieved in 49 cases
(96%). It must be noted that a direct perfusion to the
pedal arch through a crural artery was necessary for
the angioplasty to be completed. Perfusion of the
pedal arch through collaterals was not accepted as
a technical success of the procedure.
During the 12-month follow-up period, 5 patients
(10%) needed a redo angioplasty, 3 (6%) needed a
bypass operation and 4 patients (8%) required a
major amputation (above or below the knee level).
The survival analysis showed that the overall limb
salvage rate at 12 months was 92% (Fig. 1). However,
on an intention to treat basis, the primary patency
rate at 12 months was only 50% (Fig. 2). Six of the 46
patients (13%) died during the 12-month period giving
a survival rate of 82% at 12 months, according to the
Life-table analysis.
Using Cox-regression analysis we examined the
effect of all the predictor variables on the patency of
angioplasty. The variables examined were: sex, history
of arterial hypertension, ischemic heart disease, diabe-
tes mellitus and smoking, the number of patent run-off
vessels after the procedure, the length of the recanal-
ized segment and the end point of the angioplasty.
Firstly, all examined factors were univariately related
to the patency rate, and those that showed even a slight
effect on patency ( p< 0.30) were included in the
model of multivariable analysis (Table 4). By stepwise
exclusion of the variables that had the least significant
relationship to the outcome, it was concluded that the
factors that affect independently the patency are the
Table 2. Prevalence of factors predisposing to atheromatosis in our
patient cohort
Predisposing factors N %
Arterial hypertension 25 54
Ischemic cardiac disease 22 48
Smoking 22 48
Diabetes mellitus 18 39
Table 3. Patent run-off vessels after the angioplasty
Run-off vessels N %
One 25 49
Two 13 25
Three 13 25Eur J Vasc Endovasc Surg Vol 32, December 2006number of run-off vessels and the length of the
recanalized artery (Table 5).
The number of run-off vessels is strongly related
to the occlusion rate after subintimal infrainguinal
angioplasty. The risk of occlusion according to the
Cox-regression analysis of angioplastied legs with
more than one run-off vessels is 0.30 (95% CI 0.11 to
0.87, p¼ 0.027) compared to legs with one run-off
vessel. This means that patients with more than one
patent run-off vessels (two or three) have a decreased
risk of occlusion compared to the patients with one
Limb salvage







Follow up (months) 0 1 3 6 12
Patients at risk 51 50 48 32 9
Fig. 1. Limb Salvage rate: Kaplan-Meier survival curve and
Life table analysis. Censored observations are marked by
ticks on the survival curve. Times are in months.
Primary patency







Follow up (months) 0 1 3 6 12
Limbs at risk 51 45 41 29 9
Fig. 2. Primary patency rate: Kaplan-Meier survival curve and
Life table analysis. Censored observations are marked by
ticks on the survival curve. Times are in months.
671Subintimal Infrainguinal Angioplasty in Patients with Critical Lower Limb Ischemiarun-off vessel. Thus, a patient with more than one
run-off vessels has a risk of occlusion of about 0.3
times compared to the patient with one vessel run-
off, or in reverse, a one run-off angioplasty has
a 3.30 (95% CI 1.15 to 9.49) risk of occlusion compared
to a patient with two or three run-off vessels. Using
univariate survival analysis (Kaplan-Meier and Life-
table analysis) it can be seen that the 12-months pa-
tency rate in the patients that had more than one
run-off vessels was 81% while in those with only
one vessel run-off the patency was 25% at the same
time interval (Fig. 3). The log-rank test comparing
patency rates of the two groups showed that there
is a significant difference between the two groups
confirming the results of Cox-regression analysis. The
p value was less than 0.001 with a hazard ratio 4.6
(95% CI 2.0 to 10.4).
The length of angioplasty is also related to the pa-
tency rate. According to the Cox-regression analysis
the hazard for every centimeter of occlusion is 1.02
(95% CI 1.00 to 1.04, p¼ 0.049). Thus, a patient in
whom the length of the angioplasty is 50 cm has
a risk of occlusion 1.0250¼ 2.69, and compared to a
patient with a 20 cm length of angioplasty has a risk
of occlusion of 1.02(5020)¼ 1.81. By using the median
value of length of occlusion (30 cm) as a cut-off point
we can divide the patients in two groups: these in
whom the length of the recanalization was less than
30 cm and those in whom it was more than 30 cm. Us-
ing univariate analysis, the patency rates in the two
groups were significantly different (Log-rank test,
p¼ 0.005, hazard ratio¼ 3.1 with 95% CI 1.4 to 7.2).
Table 4. Univariate analysis of angioplasty patency for each risk
factor examined
Risk factors HR (95% CI) p
Sex (Male/Female) 0.70 (0.31e1.56) 0.36
Arterial hypertension (Yes/No) 1.21 (0.54e2.70) 0.62
Coronary artery disease (Yes/No) 0.92 (0.41e2.06) 0.83
Diabetes mellitus (Yes/No) 1.41 (0.61e3.30) 0.38
Smoke (Yes/No) 0.83 (0.37e1.84) 0.62
Run-off vessels (More than one/one) 0.22 (0.10e0.48) 0.00




(HR¼ hazard ratio, CI¼ confidence intervals).According to Life-table analysis the patency rate
among the patients that had a short length recanaliza-
tion (<30 cm), 12 months after the procedure was 66%
while in patients with a long recanalized segment
(>30 cm) 33% (Fig. 4).
Discussion
This prospective clinical study shows that among the
factors that can affect the patency rate of lower limb
infrainguinal subintimal angioplasty (SA), the most
important are the number of patent run-off crural ves-
sels after the procedure and the length of angioplasty.
Neither gender nor any risk factor of atherosclerosis
such as diabetes mellitus, arterial hypertension, coro-
nary artery disease and history of smoking, affect the
outcome. Also, the distal point of angioplasty (above
or below the knee level) is not a predictor of patency.
Primary patency vs. run-off vessels









Follow up (months) 0 1 3 6 12
Limbs at risk
Two or three vessels 26 25 24 16 6
One vessel 25 20 17 13 3
Fig. 3. Primary patency rate vs. run-off vessels: Kaplan-Meier
survival curves and Life table showing the primary patency
rates in legs with more than one run-off vessels and in legs
with one run-off vessel. There is a significant statistical
difference between the two groups ( p< 0.001, hazard
ratio¼ 4.6 with 95% CI 2.0 to 10.4). (Censored observations
are marked by ticks on the survival curves. Times are in
months. N: limbs at risk. %: Patency rate).Table 5. Cox regression analysis of time to occlusion on presence of predictor variables ‘‘Run-off vessels’’ and ‘‘Length of occlusion’’
Variables b SE z p HR (95% CI)
Run-off vessels 1.194 0.539 2.22 0.027 0.30 (0.11e0.87)
Length of occlusion (cm) 0.022 0.011 1.97 0.049 1.02 (1.00e1.04)
Cox-regression analysis (Chi-square¼ 6.32, df¼ 2, p¼ 0.042).
The variable ‘‘Run-off vessels’’ is a binary one and its values can be either 0 (one vessel run-off) or 1 (more than one vessel run-off). The
variable ‘‘Length of occlusion’’ is a quantitative one (centimeters of occlusion). (b¼ coefficient, SE¼ standard error of coefficient, df¼ degrees
of freedom, HR¼ hazard ratio, CI¼ confidence intervals).Eur J Vasc Endovasc Surg Vol 32, December 2006
672 A. M. Lazaris et al.The technical success of SA is generally high and
varies between 78 and 90% in different reports,3,8,14
something that was also found in our study. Accord-
ing to the literature, infrapopliteal occlusions have
a less favorable technical success rate when compared
to the femoropopliteal occlusions.3,4,14
The mortality rate at 1 year in our study was 18%
which is similar to the results of our earlier studies.5,14
The perioperative mortality rate (30 days post-
intervention) was zero which is similar to the results
reported by Nydahl et al.5 Also, Adar et al. reported
a 0.8% perioperative mortality rate in claudicant and
critically ischemic patients who had a femoropopliteal
transluminal angioplasty.15 Tisi et al. reported a 3%
mortality rate in patients who had SA for chronic
lower limb ischemia.8 It is obvious that angioplasty
carries a low incidence of perioperative mortality
something which is important especially when com-
pared to lower limbs bypass procedures that usually
have higher mortality rates.16,17
The primary patency rate in our series on an
intention-to-treat basis was 50% at 12 months which
is similar to the results reported in the literature. There
are various studies on SA that deal with either femoro-
popliteal or infrapopliteal lesions or both and report
primary patency rates that vary between 53 and
74%.4,5,18,19 In contrast, Laxdal et al. recently reported
Primary patency vs. length of angioplasty





1,00 < 30 cm
> 30 cm
Times
Follow up (months) 0 1 3 6 12
Limbs at risk
< 30 cm 26 25 23 19 6
> 30 cm 25 20 18 10 3
Fig. 4. Primary patency rate vs. length of angioplasty: Kaplan-
Meier survival curves and Life table showing the primary
patency rates in legs with a length of recanalization less
than 30 cm and in legs with a length of recanalization
more than 30 cm. There is a significant statistical difference
between the two groups ( p< 0.005, hazard ratio¼ 3.1 with
95% CI 1.4 to 7.2). Censored observations are marked by
ticks on the survival curves. Times are in months.Eur J Vasc Endovasc Surg Vol 32, December 2006a 37% primary patency in femoropopliteal subintimal
angioplasties.3 These results are low compared to by-
pass operations where patency rates are reported to
be between 80 and 98% at the same time interval.6,7,20
However, the limb salvage rate in critically ischemic
patients that had a subintimal angioplasty does not
seem to be different than in patients that had a bypass
operation. In our series, the overall limb salvage rate
at 12 months after the angioplasty was 92% despite
the 50% primary patency rate. Obviously, an occlu-
sion of the angioplastied segment is not equivalent
to limb loss. According to Leicester experience, an oc-
clusion of a SA does not definitely imply a critically
ischemic leg. It is not yet clear why there is such a dif-
ference between patency and limb salvage rate. We
believe that collaterals are the key point. In SA, collat-
erals remain intact while in a bypass operation they
are often sacrificed during the arteries dissection.
Furthermore, SA has the advantage of the repetition
as long as it is necessary. Also, the possibility of a
femoropopliteal or a femorodistal bypass operation
always exists.
With regard to the possible factors that might deter-
mine the patency rate of SA, we found that the num-
ber of patent crural vessels after the procedure and
the length of angioplasty are the most important.
According to our study, patients with 2 or 3 patent
run-off vessels after the angioplasty have a 3.30
(95% CI 1.15 to 9.49) less risk of occlusion compared
to those with one patent run-off vessel ( p¼ 0.027).
London et al.21 reported a similar result in patients
with only femoropopliteal occlusion treated by SA.
Similar results have also been reported by other inves-
tigators for percutaneous transluminal infrainguinal
angioplasty22e24 or stenting.25 Univariate analysis in
our series has shown that the patency rate of SA
with more than one run-off vessels at 12 months is
81% compared to the 25% of SA with one run-off
vessel. This could be a very important observation
as it is usually possible to recanalize more than one
occluded crural arteries using the SA technique and
we consider this safe as little harm can be caused by
trying to recanalize an occluded crural vessel.
The length of the occluded arterial segment recan-
alized was also found to be related to the patency
rate of SA by a hazard ratio of 1.02 (95% CI 1.00 to
1.04, p¼ 0.049) for every occluded centimeter. Thus,
for every 10 cm of recanalized occlusion there is about
1.0210¼ 1.22 risk of reocclusion after the angioplasty.
Vraux et al. have also reported that the length of the
occlusion (>10 cm) is a predictor of SA technical suc-
cess and patency.4 Also, London et al. consider that the
risk of reocclusion of a femoropopliteal SA increase by
1.73 for every 10 cm of occlusion length.21
673Subintimal Infrainguinal Angioplasty in Patients with Critical Lower Limb IschemiaThe end point of the angioplasty was not a signifi-
cant factor affecting the outcome of SA. Despite the
event that the univariate analysis showed an almost
statistically significant effect of this variable to angio-
plasty patency (Table 4), the multivariable Cox regres-
sion model did not prove it. Possibly, a larger number
of observation may be useful in precisely identify the
effect of this variable to the outcome. However, based
on our results we concluded that whether a femoropo-
pliteal or an infrapopliteal angioplasty was performed
they both had almost the same outcome. Vraux et al.
have also found that the location of distal reentry
point after SA is not a predictor of technical success
and patency.4
None of the factors predisposing to atherosclerosis
was found to affect the SA outcome in our series. Ar-
terial hypertension has been reported to increase the
risk of occlusion in claudicants who have invasive
treatment (endovascular or surgical),26 although
research on outcome of percutaneous transluminal
angioplasty (PTA) for CLI did not show any statistical
significance with any associated atheromatous dis-
ease.27 With regard to coronary artery disease, there
are some investigators22,28 who associate it negatively
with the long-term patency of PTA but this is not
unanimous.27 As far as diabetes mellitus is concerned
Laxdal et al.3 and Vraux et al.4 believe that this is an
independent factor for reocclusion of femoropopliteal
and tibial SA. In contrast, Ingle et al. reported that
although the rate of CLI is significantly higher in
diabetics than non-diabetics, neither survival nor
amputation rates are different.14 However, it is likely
that the effects of diabetes and CLI are confounded
by run-off status and the extent of the occlusive
disease. Diabetic patients with good run-off fare better
than those with poor run-off after femoropopliteal
PTA.29 Diabetics in whom run-off can be restored by
tibioperoneal PTA also fare well.30 A history of smok-
ing is not related to the angioplasty outcome27 but the
continuation of smoking after the procedure is related
to a higher reocclusion rate.21 It is well known that the
progression of peripheral arterial disease from asymp-
tomatic to claudication and finally to ischemic rest
pain is associated with cigarette smoking.31 In patients
with severe disease, graft patencies are clearly
improved by stopping smoking, both for vein as well
as prosthetic graft material.7 Therefore, in patients
with severe end-stage disease, smoking cessation is
highly beneficial.
Sex was not found to be a significant risk factor in
our study. In the literature, there are controversial
thoughts on this. Timaran et al. believe that female
gender is an independent factor for decreased pri-
mary iliac stent patency32,33 while Marzelle et al.have reported a statistically higher incidence of reste-
nosis of infrainguinal endovascular revascularization
procedures among men.34
As a weakness of this study, it could be considered
the relatively small number of patients that does not
permit a further stratification of the results. This is
the reason why we have just remained on the distinc-
tion between one and more than one run-off vessels
and have not studied further down the difference
between two and three run-off vessels.
Subintimal angioplasty is a different technique to
transluminal angioplasty; not only are there technical
differences but also because SA achieves recanaliza-
tion of long arterial occlusions which PTA cannot. In
transluminal angioplasty selection on anatomical
ground is important because the ideal patient will
be the one with focal disease. Unfortunately, because
of the presence of diffuse disease in chronic CLI,
transluminal angioplasty is only applicable in a small
proportion of CLI patients. In contrast, SA due to its
effectiveness in long occlusions can be applied to
most patients with CLI. Thus SA can be considered
as an alternative to open surgery for these patients.
The treatment is relatively atraumatic, complications
are rare8 and in most cases treated by endovascular
techniques.3,35 Our data suggests that the number of
run-off vessels and the length of occlusion are the
main determinants of SA patency. This knowledge
could alter on SA technique as a recanalization of
more than one vessel is often achievable. By recanali-
zation of more than one run-off vessels when possible
during SA, patency rates could be raised to bypass
levels.
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